Nasdaq · CIK 0001875558
NVCT Nuvectis Pharma, Inc.
Insider trading from SEC Form 4. Last filing Jun 12, 2026. Close $21.12 on Oct 9, 2026, +274% from the 52-week low and -26% from the high.
Nuvectis Pharma, Inc. (NVCT) has 26 SEC Form 4 filings on file from 9 insiders, the latest filed on Jun 12, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
15 open-market trades have been scored at NVCT. The newest: Ron Bentsur (Chairman & CEO) bought $29k of stock on Nov 5, 2025, filed Nov 6, 2025, scored 48 (moderate). The largest of the 15 shown: Marlio Charles Mosseri (10% owner) bought $957k on Oct 23, 2025, scored 57 (moderate). 4 insiders bought within 14 days of each other around Nov 5, 2025.
NVCT closed at $21.12 on Oct 9, 2026, 274% above its 52-week low and 26% below its 52-week high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Nuvectis Pharma, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 48Moderate | Ron Bentsur Chairman & CEO buy | $29k 5,000 shares | +0% | +25% from low-49% from high | |
| 49Moderate | Matthew L. Kaplan director buy | $64k 11,000 shares | +10% | +25% from low-49% from high | |
| 49Moderate | Juan Sanchez director buy | $75k 13,000 shares | +20% | +25% from low-49% from high | |
| 57Moderate | Marlio Charles Mosseri owner buy | $957k 154,770 shares | +5% | +33% from low-45% from high | |
| 17Weak | Marlio Charles Mosseri owner buy | $45k 5,603 shares | +0% | +80% from low-26% from high | |
| 29Weak | Marlio Charles Mosseri owner buy | $270k 33,442 shares | +1% | +79% from low-26% from high | |
| 22Weak | Marlio Charles Mosseri owner buy | $172k 21,167 shares | +1% | +86% from low-24% from high | |
| 24Weak | Marlio Charles Mosseri owner buy | $247k 27,662 shares | +1% | +104% from low-16% from high | |
| 19Weak | Marlio Charles Mosseri owner buy | $236k 27,411 shares | +1% | +98% from low-18% from high | |
| 33Weak | Ron Bentsur Chairman & CEO buy | $21k 4,500 shares | +0% | - | |
| 24Weak | Marlio Charles Mosseri owner buy | $80k 17,000 shares | +1% | - | |
| 28Weak | Marlio Charles Mosseri owner buy | $229k 49,121 shares | +2% | - | |
| 18Weak | Enrique Poradosu Chief Science & Business Off buy | $9,980 2,000 shares | +0% | - | |
| 38Weak | Ron Bentsur Chairman & CEO buy | $98k 20,000 shares | +1% | - | |
| 15Weak | Michael J. Carson Vice President, Finance sell | $22k 2,755 shares | -3% | - |
Transactions
Every row filed, 44 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | Kenneth Hoberman director | AGrant or award Common Stock | +35,000 | $0.00 | $0 | 168,140 | Jun 12, 2026 |
| Jan 6, 2026 | Ron Bentsur Chairman & CEO | AGrant or award Common Stock | +150,000 | $0.00 | $0 | 3,675,924 | Jan 9, 2026 |
| Jan 6, 2026 | Michael J. Carson Vice President, Finance | AGrant or award Common Stock | +61,200 | $0.00 | $0 | 200,118 | Jan 9, 2026 |
| Jan 6, 2026 | Enrique Poradosu Chief Science & Business Off | AGrant or award Common Stock | +150,000 | $0.00 | $0 | 1,806,319 | Jan 9, 2026 |
| Jan 6, 2026 | Shay Shemesh Chief Dev. & Ops. Officer | AGrant or award Common Stock | +150,000 | $0.00 | $0 | 1,793,068 | Jan 9, 2026 |
| Nov 5, 2025 | Ron Bentsur Chairman & CEO | POpen-market purchase Common Stock | +5,000 | $5.72 | $29k | 3,525,924 | Nov 6, 2025 |
| Nov 5, 2025 | Matthew L. Kaplan director | POpen-market purchase Common Stock | +11,000 | $5.84 | $64k | 124,760 | Nov 6, 2025 |
| Nov 5, 2025 | Juan Sanchez director | POpen-market purchase Common Stock | +13,000 | $5.79 | $75k | 78,150 | Nov 6, 2025 |
| Sep 22, 2025 | Juan Sanchez director | AGrant or award Common Stock | +30,000 | $0.00 | $0 | 65,150 | Oct 31, 2025 |
| Oct 23, 2025 | Marlio Charles Mosseri owner | POpen-market purchase Common Stockindirect: By Emerald Hill Ventures SARL SPF. | +46,900 | $6.06 | $284k | 3,028,706 | Oct 29, 2025 |
| Oct 24, 2025 | Marlio Charles Mosseri owner | POpen-market purchase Common Stockindirect: By Emerald Hill Ventures SARL SPF. | +35,034 | $6.15 | $215k | 3,063,740 | Oct 29, 2025 |
| Oct 27, 2025 | Marlio Charles Mosseri owner | POpen-market purchase Common Stockindirect: By Emerald Hill Ventures SARL SPF. | +72,836 | $6.28 | $457k | 3,136,576 | Oct 29, 2025 |
| Jun 20, 2025 | Marlio Charles Mosseri owner | POpen-market purchase Common Stockindirect: By Emerald Hill Ventures SARL SPF. | +5,603 | $7.99 | $45k | 2,981,806 | Jun 24, 2025 |
| Jun 17, 2025 | Marlio Charles Mosseri owner | POpen-market purchase Common Stockindirect: By Emerald Hill Ventures SARL SPF. | +5,399 | $8.11 | $44k | 2,948,160 | Jun 20, 2025 |
| Jun 18, 2025 | Marlio Charles Mosseri owner | POpen-market purchase Common Stockindirect: By Emerald Hill Ventures SARL SPF. | +28,043 | $8.05 | $226k | 2,976,203 | Jun 20, 2025 |
| Jun 12, 2025 | Kenneth Hoberman director | AGrant or award Common Stock | +30,000 | $0.00 | $0 | 133,140 | Jun 12, 2025 |
| Jun 12, 2025 | James F Oliviero III director | AGrant or award Common Stock | +30,000 | $0.00 | $0 | 87,828 | Jun 12, 2025 |
| Jun 12, 2025 | Matthew L. Kaplan director | AGrant or award Common Stock | +30,000 | $0.00 | $0 | 113,760 | Jun 12, 2025 |
| May 12, 2025 | Marlio Charles Mosseri owner | POpen-market purchase Common Stockindirect: By Emerald Hill Ventures SARL SPF. | +21,167 | $8.11 | $172k | 2,942,761 | May 13, 2025 |
| May 8, 2025 | Marlio Charles Mosseri owner | POpen-market purchase Common Stockindirect: By Emerald Hill Ventures SARL SPF. | +100 | $8.99 | $899 | 2,909,032 | May 12, 2025 |
| May 8, 2025 | Marlio Charles Mosseri owner | POpen-market purchase Common Stockindirect: By Emerald Hill Ventures SARL SPF. | +100 | $8.71 | $871 | 2,909,132 | May 12, 2025 |
| May 8, 2025 | Marlio Charles Mosseri owner | POpen-market purchase Common Stockindirect: By Emerald Hill Ventures SARL SPF. | +2,400 | $8.97 | $22k | 2,911,532 | May 12, 2025 |
| May 9, 2025 | Marlio Charles Mosseri owner | POpen-market purchase Common Stockindirect: By Emerald Hill Ventures SARL SPF. | +9,850 | $8.95 | $88k | 2,921,382 | May 12, 2025 |
| May 9, 2025 | Marlio Charles Mosseri owner | POpen-market purchase Common Stockindirect: By Emerald Hill Ventures SARL SPF. | +9,817 | $8.90 | $87k | 2,931,199 | May 12, 2025 |
| May 9, 2025 | Marlio Charles Mosseri owner | POpen-market purchase Common Stockindirect: By Emerald Hill Ventures SARL SPF. | +5,395 | $8.98 | $48k | 2,936,594 | May 12, 2025 |
| May 6, 2025 | Marlio Charles Mosseri owner | POpen-market purchase Common Stockindirect: By Emerald Hill Ventures SARL SPF. | +2,340 | $8.40 | $20k | 2,886,461 | May 9, 2025 |
| May 6, 2025 | Marlio Charles Mosseri owner | POpen-market purchase Common Stockindirect: By Emerald Hill Ventures SARL SPF. | +10,104 | $8.64 | $87k | 2,896,565 | May 9, 2025 |
| May 7, 2025 | Marlio Charles Mosseri owner | POpen-market purchase Common Stockindirect: By Emerald Hill Ventures SARL SPF. | +2,703 | $8.40 | $23k | 2,899,268 | May 9, 2025 |
| May 7, 2025 | Marlio Charles Mosseri owner | POpen-market purchase Common Stockindirect: By Emerald Hill Ventures SARL SPF. | +9,614 | $8.64 | $83k | 2,908,882 | May 9, 2025 |
| May 8, 2025 | Marlio Charles Mosseri owner | POpen-market purchase Common Stockindirect: By Emerald Hill Ventures SARL SPF. | +50 | $8.65 | $433 | 2,908,932 | May 9, 2025 |
| May 8, 2025 | Marlio Charles Mosseri owner | POpen-market purchase Common Stockindirect: By Emerald Hill Ventures SARL SPF. | +100 | $8.65 | $865 | 2,909,032 | May 9, 2025 |
| May 8, 2025 | Marlio Charles Mosseri owner | POpen-market purchase Common Stockindirect: By Emerald Hill Ventures SARL SPF. | +100 | $8.65 | $865 | 2,909,132 | May 9, 2025 |
| May 8, 2025 | Marlio Charles Mosseri owner | POpen-market purchase Common Stockindirect: By Emerald Hill Ventures SARL SPF. | +2,400 | $8.65 | $21k | 2,911,532 | May 9, 2025 |
| Jan 2, 2025 | Ron Bentsur Chairman & CEO | AGrant or award Common Stock | +250,000 | $0.00 | $0 | 3,520,924 | Jan 3, 2025 |
| Jan 2, 2025 | Michael J. Carson Vice President, Finance | AGrant or award Common Stock | +51,000 | $0.00 | $0 | 138,918 | Jan 3, 2025 |
| Dec 24, 2024 | Ron Bentsur Chairman & CEO | POpen-market purchase Common Stock | +4,500 | $4.65 | $21k | 3,270,924 | Dec 26, 2024 |
| Dec 13, 2024 | Marlio Charles Mosseri owner | POpen-market purchase Common Stock | +17,000 | $4.70 | $80k | 2,612,000 | Dec 16, 2024 |
| Dec 12, 2024 | Marlio Charles Mosseri owner | POpen-market purchase Common Stock | +32,121 | $4.64 | $149k | 2,627,121 | Dec 16, 2024 |
| Dec 13, 2024 | Marlio Charles Mosseri owner | POpen-market purchase Common Stock | +17,000 | $4.70 | $80k | 2,644,121 | Dec 16, 2024 |
| Nov 19, 2024 | Enrique Poradosu Chief Science & Business Off | POpen-market purchase Common Stock | +2,000 | $4.99 | $9,980 | 1,506,319 | Nov 20, 2024 |
| Nov 15, 2024 | Ron Bentsur Chairman & CEO | POpen-market purchase Common Stock | +20,000 | $4.92 | $98k | 3,266,424 | Nov 18, 2024 |
| Jan 3, 2023 | Michael J. Carson Vice President, Finance | AGrant or award Common Stock | +28,806 | $0.00 | $0 | 56,106 | Nov 8, 2024 |
| Jan 4, 2024 | Michael J. Carson Vice President, Finance | AGrant or award Common Stock | +34,567 | $0.00 | $0 | 90,673 | Nov 8, 2024 |
| Nov 7, 2024 | Michael J. Carson Vice President, Finance | SOpen-market sale Common Stock | -2,755 | $8.16 | $22k | 87,918 | Nov 8, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Ron BentsurChairman & CEO
- Michael J. CarsonVice President, Finance
- Kenneth Hobermandirector
- Matthew L. Kaplandirector
- Marlio Charles Mosseriowner
- James F Oliviero IIIceo, president, officer, director
- Enrique PoradosuChief Science & Business Off
- Juan Sanchezdirector
- Shay ShemeshChief Dev. & Ops. Officer
Questions about NVCT
Answered from the filings on this page, as of the latest one.
Are insiders buying NVCT?
No. In the last 90 days no insider at Nuvectis Pharma, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade NVCT on the open market?
Ron Bentsur (Chairman & CEO) bought $29k of NVCT on Nov 5, 2025 and filed the Form 4 on Nov 6, 2025. InsiderTell scored 48 (moderate), with 4 insiders on the same side within 14 days.
How many insiders file Form 4 at Nuvectis Pharma, Inc.?
9 people have filed a Form 4 at Nuvectis Pharma, Inc., among them Ron Bentsur (Chairman & CEO), Michael J. Carson (Vice President, Finance), Kenneth Hoberman (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.